See more : Bellway p.l.c. (BLWYF) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Sanyou Medical Co., Ltd. (688085.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Sanyou Medical Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Oxford BioDynamics Plc (OBD.L) Income Statement Analysis – Financial Results
- OmniLit Acquisition Corp. (OLIT) Income Statement Analysis – Financial Results
- Alphax Food System Co., Ltd (3814.T) Income Statement Analysis – Financial Results
- AngioGenex Inc (AGGX) Income Statement Analysis – Financial Results
- GigaDevice Semiconductor (Beijing) Inc. (603986.SS) Income Statement Analysis – Financial Results
Shanghai Sanyou Medical Co., Ltd. (688085.SS)
About Shanghai Sanyou Medical Co., Ltd.
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and z-minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee system, knee system, and palm and wrist systems. Shanghai Sanyou Medical Co., Ltd. is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 454.38M | 649.15M | 593.36M | 390.43M | 354.32M | 222.31M | 139.97M | 75.29M |
| Cost of Revenue | 103.81M | 63.77M | 56.37M | 35.63M | 30.96M | 25.46M | 30.47M | 18.60M |
| Gross Profit | 350.58M | 585.38M | 536.99M | 354.80M | 323.36M | 196.85M | 109.50M | 56.68M |
| Gross Profit Ratio | 77.15% | 90.18% | 90.50% | 90.87% | 91.26% | 88.55% | 78.23% | 75.29% |
| Research & Development | 65.22M | 60.38M | 56.55M | 33.92M | 18.45M | 13.31M | 12.76M | 12.28M |
| General & Administrative | 8.40M | 14.34M | 11.54M | 7.16M | 6.65M | 3.16M | 27.47M | 9.07M |
| Selling & Marketing | 120.57M | 296.96M | 294.77M | 185.92M | 176.03M | 103.54M | 50.74M | 24.01M |
| SG&A | 176.31M | 311.30M | 306.31M | 193.08M | 182.68M | 106.70M | 78.21M | 33.08M |
| Other Expenses | -13.78M | 24.75M | 21.53M | 15.29M | 6.89M | 3.30M | 1.17M | 1.94M |
| Operating Expenses | 236.16M | 396.43M | 384.39M | 242.29M | 208.02M | 126.22M | 97.69M | 46.46M |
| Cost & Expenses | 339.97M | 460.19M | 440.76M | 277.93M | 238.97M | 151.69M | 128.16M | 65.07M |
| Interest Income | 16.25M | 9.25M | 7.86M | 3.23M | 188.63K | 205.98K | 560.94K | 0.00 |
| Interest Expense | 491.95K | 202.85K | 160.74K | 45.93K | 64.37K | 22.97K | 19.23K | 0.00 |
| Depreciation & Amortization | 30.03M | 34.22M | 28.14M | 19.37M | 12.10M | 9.72M | 7.90M | 5.08M |
| EBITDA | 165.17M | 277.65M | 245.73M | 156.36M | 126.06M | 81.40M | 17.32M | 15.30M |
| EBITDA Ratio | 36.35% | 35.88% | 36.31% | 32.77% | 36.95% | 37.23% | 16.34% | 34.63% |
| Operating Income | 120.43M | 229.09M | 204.02M | 130.38M | 109.34M | 68.36M | 8.23M | 1.13M |
| Operating Income Ratio | 26.50% | 35.29% | 34.38% | 33.39% | 30.86% | 30.75% | 5.88% | 1.51% |
| Total Other Income/Expenses | 14.44M | 10.45M | 13.31M | 6.56M | 4.62M | 3.30M | 1.17M | 1.94M |
| Income Before Tax | 134.87M | 239.54M | 217.33M | 136.95M | 113.96M | 71.66M | 9.40M | 3.08M |
| Income Before Tax Ratio | 29.68% | 36.90% | 36.63% | 35.08% | 32.16% | 32.23% | 6.71% | 4.08% |
| Income Tax Expense | 21.23M | 35.99M | 22.18M | 18.39M | 15.90M | 9.69M | 4.71M | -54.44K |
| Net Income | 95.58M | 190.82M | 186.37M | 118.56M | 97.82M | 62.14M | 5.20M | 3.13M |
| Net Income Ratio | 21.04% | 29.39% | 31.41% | 30.37% | 27.61% | 27.95% | 3.72% | 4.16% |
| EPS | 0.38 | 0.77 | 0.75 | 0.48 | 0.39 | 0.33 | 0.03 | 0.02 |
| EPS Diluted | 0.38 | 0.77 | 0.75 | 0.48 | 0.39 | 0.33 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 251.53M | 248.45M | 248.45M | 248.45M | 248.45M | 187.95M | 157.16M | 189.34M |
| Weighted Avg Shares Out (Dil) | 251.53M | 248.45M | 248.45M | 248.45M | 248.45M | 187.97M | 157.36M | 189.34M |
Source: https://incomestatements.info
Category: Stock Reports